Sanders, Cummings Request Info on FDA’s Emflaza Approval
Two lawmakers have asked the FDA to explain why the agency approved Marathon’s application to market the old drug Emflaza (deflazacort) as a new treatment for Duchenne muscular dystrophy.
Source: Drug Industry Daily